# Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee Pain

> **NCT01518257** · PHASE1,PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 121 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01518257
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2014-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518257, "Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01518257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*